Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Equillium Inc (EQ)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,730,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Equillium is a clinical-stage biotechnology company to develop therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Co.'s pipeline is focused on developing itolizumab (EQ001), EQ101 and EQ102 as potential disease modifying treatments for multiple severe immuno-inflammatory disorders. Co. has active clinical development programs for itolizumab (EQ001) for the treatment of acute graft-versus-host disease and lupus/lupus nephritis. Co. also has a proprietary product discovery platform that it can utilize to design peptides to target and inhibit multiple cytokines that are involved in validated biological and disease pathways.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 20,000 87,324 87,324
Total Sell Value $0 $13,500 $78,333 $78,333
Total People Sold 0 1 3 3
Total Sell Transactions 0 2 7 7
End Date 2025-02-02 2024-11-01 2024-05-03 2023-05-04

   
Records found: 59
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Keyes Jason A Chief Financial Officer   •       –      –    2025-01-23 4 AS $0.65 $6,500 I/I (10,000) 37,720     -
   Keyes Jason A Chief Financial Officer   •       –      –    2024-12-10 4 A $0.54 $8,100 D/D 15,000 88,913     -
   Keyes Jason A Chief Financial Officer   •       –      –    2024-11-14 4 AS $0.70 $7,000 I/I (10,000) 47,720     -
   Zedelmayer Christine Sr. Vice President and COO   •       –      –    2024-10-28 4 AS $1.25 $18,750 D/D (15,000) 135,246     -
   Tom Penny Principal Accounting Officer   •       –      –    2024-10-28 4 AS $1.25 $3,544 D/D (2,835) 6,533     -
   Tom Penny Principal Accounting Officer   •       –      –    2024-10-25 4 AS $1.25 $854 D/D (683) 9,368     -
   Tom Penny Principal Accounting Officer   •       –      –    2024-09-16 4 AS $0.85 $32,985 D/D (38,806) 10,051     -
   Keyes Jason A Chief Financial Officer   •       –      –    2024-07-16 4 AS $0.87 $8,700 I/I (10,000) 67,720     -
   Tom Penny Principal Accounting Officer   •       –      –    2024-03-06 3 IO $0.00 $0 D/D 0 33,857     -
   Keyes Jason A Chief Financial Officer   •       –      –    2023-12-08 4 A $0.58 $5,107 D/D 8,805 58,913     -
   Zedelmayer Christine Sr. Vice President and COO   •       –      –    2023-12-08 4 A $0.58 $5,106 D/D 8,804 135,246     -
   Rothman Joel Chief Development Officer   •       –      –    2023-12-08 4 A $0.58 $5,106 D/D 8,804 58,150     -
   Keyes Jason A Chief Financial Officer   •       –      –    2023-06-09 4 A $0.56 $8,400 D/D 15,000 50,108     -
   Zedelmayer Christine Sr. Vice President and COO   •       –      –    2023-06-09 4 A $0.56 $8,400 D/D 15,000 126,442     -
   Rothman Joel Chief Development Officer   •       –      –    2023-06-09 4 A $0.56 $8,400 D/D 15,000 49,346     -
   Rothman Joel Chief Development Officer   •       –      –    2022-12-09 4 A $1.19 $4,547 D/D 3,821 34,346     -
   Keyes Jason A Chief Financial Officer   •       –      –    2022-12-09 4 A $1.19 $5,288 D/D 4,444 35,108     -
   Keyes Jason A Chief Financial Officer   •       –      –    2022-08-29 4 AS $2.83 $19,810 I/I (7,000) 77,720     -
   Zedelmayer Christine Sr. Vice President and COO   •       –      –    2022-06-10 4 A $1.85 $16,711 D/D 9,033 111,442     -
   Rothman Joel Chief Development Officer   •       –      –    2022-06-10 4 A $1.85 $11,551 D/D 6,244 30,525     -
   Keyes Jason A Chief Financial Officer   •       –      –    2022-06-06 4 AS $2.52 $12,600 I/I (5,000) 84,720     -
   Keyes Jason A Chief Financial Officer   •       –      –    2022-04-04 4 AS $3.18 $25,440 I/I (8,000) 89,720     -
   Keyes Jason A Chief Financial Officer   •       –      –    2021-12-10 4 A $2.35 $13,125 D/D 5,585 23,296     -
   Rothman Joel Chief Development Officer   •       –      –    2021-12-10 4 A $2.35 $3,032 D/D 1,290 24,281     -
   Keyes Jason A Chief Financial Officer   •       –      –    2021-12-01 4 AS $5.08 $25,402 I/I (5,000) 97,720     -

  59 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed